Nucleo Longevity

Pterostilbene

pterostilbene

A resveratrol relative with better absorption, often paired with NMN or NR.

TypeSupplement / dietary

The grade answers: What does the human evidence support for: Sirtuin / antioxidant activity?

Grade

C

Limited

The grade rates evidence quality — it is not advice to take or buy.

Class
Polyphenol
Primary use
Sirtuin / antioxidant activity
Evidence strength
low
Last reviewed
2026-07-01

Bottom line

More bioavailable than resveratrol on paper, but with far less human data of its own. Frequently bundled with NAD⁺ precursors on theory, not on outcome evidence.

What the evidence says

Pterostilbene is a methylated analogue of resveratrol found in blueberries, with better oral bioavailability and a longer half-life — which is often used to argue it's 'resveratrol done right'. The problem is that improved pharmacokinetics haven't been matched by a comparable body of human outcome trials; the clinical evidence is small and mixed (some effect on cholesterol and blood pressure, with a possible LDL-raising signal at higher doses). It's commonly sold combined with NR/NMN based on mechanism rather than proven synergy. Grade C: better absorption, thin human proof.

Key studies

  1. [1]

    Pterostilbene human trial (blood pressure, lipids) · RCT

    Some cardiovascular-marker effects; possible LDL rise at higher dose.

    Open on PubMed
  2. [2]

    Pterostilbene vs resveratrol bioavailability · pharmacokinetic

    Better absorbed and longer-lasting than resveratrol.

    Open on PubMed
  3. [3]

    Pterostilbene pharmacology (review) · review

    Mechanistic case; limited outcome data.

    Open on PubMed
See all studies on PubMed

Mechanism

Proposed SIRT1 activation and antioxidant effects similar to resveratrol, with greater metabolic stability and cell membrane permeability.

Safety

Limited long-term human safety data; some trials noted increases in LDL cholesterol at higher doses, so it isn't automatically benign. Generally well tolerated short-term.

Dosage context

Human trials have used roughly 50–125 mg/day. Optimal dose and any real benefit of NMN/NR co-formulation are not established by outcome data.

Examples of application

  • Taken ~50–125 mg/day, often bundled with NMN/NR.
  • Watched for a possible LDL rise at higher doses.
  • Better absorbed than resveratrol, but with far less human data.

From the field

Pterostilbene is 'resveratrol with better PK' — which fixes the absorption complaint without supplying the missing human outcomes. We grade it C and note the LDL signal the bundled products rarely mention.

Related molecules